Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months
Diabetes Technology & Therapeutics · 2025
DOI: 10.1089/dia.2024.0481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Satish K Garg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Obesity, Overweight, Cardiovascular Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, USA.
ORCID-Profile: Satish K Garg, Janet Snell-Bergeon
Zitieren
APA
Garg, S. K., Kaur, G., Renner, D., Lanning, M. S., Mason, E., Beatson, C., Ciesco, K., & Snell-Bergeon, J. (2025). Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0481
Vancouver
Garg SK, Kaur G, Renner D, Lanning MS, Mason E, Beatson C, et al. Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0481
BibTeX
@article{Garg2025,
author = {Garg, Satish K and Kaur, Gurleen and Renner, Drew and Lanning, Monica S and Mason, Emma and Beatson, Christie and Ciesco, Kelly and Snell-Bergeon, Janet},
title = {Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
doi = {10.1089/dia.2024.0481}
}
EUVIMED